Greg Durm, Md

This study looks at whether giving the drug pembrolizumab after surgery can help prevent stage I non-small cell lung cancer from returning. About 244 people who had their tumor removed will be randomly assigned to receive either pembrolizumab infusions every 6 weeks for about a y…